Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial
- PMID: 12671696
- PMCID: PMC2376383
- DOI: 10.1038/sj.bjc.6600824
Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial
Abstract
Mucositis is an acute inflammation of the oral mucosa because of radiotherapy and/or chemotherapy. All patients receiving radiotherapy in the head and neck region develop oral mucositis. The aim of this study was to analyse the effects of selective oral flora elimination on radiotherapy-induced oral mucositis, in a double-blind, randomised, placebo-controlled trial. Sixty-five patients with a malignant tumour in the head and neck regions to be treated with primary curative or postoperative radiotherapy participated in this study. The patients received either the active lozenges of 1 g containing polymyxin E 2 mg, tobramycin 1.8 mg and amphotericin B 10 mg (PTA) (33 patients) or the placebo lozenges (32 patients), four times daily during the full course of radiotherapy. Mucositis, changes in the oral flora, quality of feeding and changes of total body weight were assessed. Mucositis score did not differ between the groups during the first 5 weeks of radiotherapy. Nasogastric tube feeding was needed in six patients (19%) of the placebo group and two patients (6%) of the PTA group (P=0.08). Mean weight loss after 5 weeks of radiation was less in the PTA group (1.3 kg) (s.d.: 3.0) than in the placebo group (2.8 kg) (s.d.: 2.9) (P=0.05). Colonisation index of Candida species and Gram-negative bacilli was reduced in the PTA group and not in the placebo group (P<0.05). No effect on other microorganisms was detected. In conclusion, selective oral flora elimination in head and neck irradiation patients does not prevent the development of severe mucositis.
Figures



Similar articles
-
Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study.Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):343-52. doi: 10.1016/s0360-3016(01)01444-4. Int J Radiat Oncol Biol Phys. 2001. PMID: 11380220 Clinical Trial.
-
Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients.J Oral Pathol Med. 1990 Nov;19(10):486-9. doi: 10.1111/j.1600-0714.1990.tb00792.x. J Oral Pathol Med. 1990. PMID: 2286929 Clinical Trial.
-
Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.Am J Clin Nutr. 2019 Mar 1;109(3):606-614. doi: 10.1093/ajcn/nqy329. Am J Clin Nutr. 2019. PMID: 30753262 Free PMC article. Clinical Trial.
-
Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.J Dent Res. 2006 Aug;85(8):690-700. doi: 10.1177/154405910608500802. J Dent Res. 2006. PMID: 16861284 Review.
-
[How I treat...oropharyngeal mucositis associated with radiotherapy for head and neck cancer].Rev Med Liege. 2004 Mar;59(3):120-7. Rev Med Liege. 2004. PMID: 15139398 Review. French.
Cited by
-
The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome-Treatment Axis.Int J Mol Sci. 2020 Oct 29;21(21):8061. doi: 10.3390/ijms21218061. Int J Mol Sci. 2020. PMID: 33137960 Free PMC article. Review.
-
An increase in Fusobacterium is associated with the severity of oral mucositis after radiotherapy.Sci Rep. 2025 Aug 6;15(1):28706. doi: 10.1038/s41598-025-14125-6. Sci Rep. 2025. PMID: 40770419 Free PMC article.
-
Probiotics in the management of radiation-induced oral mucositis.Front Cell Infect Microbiol. 2024 Sep 18;14:1477143. doi: 10.3389/fcimb.2024.1477143. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39359935 Free PMC article. Review.
-
Preventive effect of probiotics on oral mucositis induced by anticancer therapy: a systematic review and meta-analysis of randomized controlled trials.BMC Oral Health. 2024 Sep 29;24(1):1159. doi: 10.1186/s12903-024-04955-7. BMC Oral Health. 2024. PMID: 39343876 Free PMC article.
-
The Role of the Innate Immune Response in Oral Mucositis Pathogenesis.Int J Mol Sci. 2023 Nov 14;24(22):16314. doi: 10.3390/ijms242216314. Int J Mol Sci. 2023. PMID: 38003503 Free PMC article. Review.
References
-
- Anonymous (1979) Handbook for Reporting Results of Cancer Treatment, Vol. 48. 15–22. WHO Offset Publication.
-
- Anonymous (1993) ICRU Report 50: Prescribing, Recording and Reporting Photon Beam Therapy. Bethesda, MD: ICRU Publications
-
- Baker DG. (1982) The radiobiological basis for tissue reactions in the oral cavity following therapeutic X-irradiation. A review. Arch Otolaryngol 108: 21–24 - PubMed
-
- Bernhoft CH, Skaug N (1985) Oral findings in irradiated edentulous patients. Int J Oral Surg 14: 416–427 - PubMed
-
- Jansma J, Vissink A, Spijkervet FKL, Roodenburg JLN, Panders AK, Vermey A, Szabo BG, Gravenmade EJ (1992) Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 70: 2171–2180 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical